Merck & Co., Inc. is 131.8x more valuable than Day One Biopharmaceuticals, Inc. by market capitalization ($293.16 B vs $2.22 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | DAWN | MRK |
|---|---|---|
| Market cap | $2.22 B | $293.16 B |
| US-listed rank | #2029 | #44 |
| Revenue (latest FY) | $158.18M | $65.01B |
| Net income (latest FY) | -$107.32B | $18.25B |
| Net margin | -67847.2% | 28.1% |
| P/E (trailing FY) | - | 16.1 |
| SEC filings | 493 | 996 |
Merck & Co., Inc. is 131.8x more valuable than Day One Biopharmaceuticals, Inc. by market capitalization ($293.16 B vs $2.22 B).
In their latest fiscal years, Day One Biopharmaceuticals, Inc. reported $158.18M in revenue while Merck & Co., Inc. reported $65.01B.
Full pages: Day One Biopharmaceuticals, Inc. and Merck & Co., Inc., or browse the full rankings.